Nanopore-Based Metagenomic Sequencing in Respiratory Tract Infection: A Developing Diagnostic Platform.

Authors:
Chapman R; Jones L; D'Angelo A; Suliman A; Anwar M and 1 more

Journal:
Lung

Publication Year: 2023

DOI:
10.1007/s00408-023-00612-y

PMCID:
PMC10067523

PMID:
37009923

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Lung

Abbreviation: Lung

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Elevated Eosinophil Counts in Acute Exacerbations of Bronchiectasis: Unveiling a Distinct Clinical …
Chen W; Ran S; Li C and 4 more (2024) - Transparency Score: 3/6
Analytic Morphomics in Myositis-Related Interstitial Lung Disease.
O'Mahony AT; Henry PJ; Coghlan P and 8 more (2023) - Transparency Score: 3/6
Chronic Cough as a Genetic Neurological Disorder? Insights from Cerebellar Ataxia with Neuropathy a…
Turner RD; Hirons B; Cortese A and 1 more (2023) - Transparency Score: 3/6
Early Exacerbation Relapse is Increased in Patients with Asthma and Bronchiectasis (a Post hoc Anal…
Hill AR; Bedi P; Cartlidge MK and 8 more (2023) - Transparency Score: 4/6
Efficacy and Safety of Eliapixant in Refractory Chronic Cough: The Randomized, Placebo-Controlled P…
Dicpinigaitis PV; Morice AH; Smith JA and 11 more (2023) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestRC, AS, MA, SB: report no conflicts of interest or funding related to this work. LJ is a PhD candidate partly funded by Oxford Nanopore Technologies. Conflict of interest RC, AS, MA, SB: report no conflicts of interest or funding related to this work. LJ is a PhD candidate partly funded by Oxford Nanopore Technologies."

Evidence found in paper:

"Funding The authors have not disclosed any funding."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025